About Us

Pioneering a New Branch of Medicine

CellSonic Ltd is biophysics technology for chronic disease through Very Intense Pressure Pulse technology. Non-invasive, no side effects, no drugs.

Our Story

We have all at some time been helped by surgery and pharmaceuticals. It may have only been a stitch to close a wound or a pill to block pain but without these long standing medical methods we may not have got to where we are now.

But what if that wound had been infected and turned to gangrene and if that pain had been caused by the early stages of cancer — would we have survived? Most likely we would have died. Traditional medicine struggles with wounds, cancer, psoriasis, periodontal infection and many other common, debilitating diseases.

It is in these areas where surgery and pharmaceuticals fail that CellSonic succeeds. We give you a new branch of medicine. There are no side effects, no risks, it is non-invasive and the costs are low.

The technology is based on the pressure pulses developed forty years ago to pulverise kidney stones. CellSonic has made the machines smaller, weaker, faster and much lower in price. The main advance is the high voltage switching used to make the high pressure pulses.

It is the fast switching of the CellSonic medical machine that makes it unique. The intense pressure pulse it produces kills all infection, increases vascularisation, repairs nerves and stops cancer. No drugs can do all this so efficiently and safely. CellSonic works with the immune system to heal without the risk of collateral damage.

CellSonic Ltd

Our Journey

1987

Shockwave technology development begins for lithotripsy

1990s

First medical applications beyond kidney stones explored

2002

VIPP (Very Intense Pressure Pulse) technology invented

2007

CellSonic Ltd formally established

2012

First wound healing clinical results published

2016

Cancer and cell voltage research applications pioneered

2020

Sapiens Shield launched for surface sterilisation

2022

CE & ISO 13485:2016 medical device certification achieved

Today

3000+ global CellSonic community across 30+ conditions

Prof. Andrew Hague

Prof. Andrew Hague

President, CellSonic Ltd

BiophysicsInnovation

Leadership

Professor Andrew Hague is the founder and president of CellSonic Ltd. With decades of experience in engineering and medical technology, he recognised that the principles of lithotripsy — the use of pressure waves to break kidney stones — could be repurposed to treat a vastly wider range of medical conditions.

Under his leadership, CellSonic developed VIPP technology, which uniquely combines three physical forces — pressure waves, light energy, and an electrical field — to stimulate the body's own healing mechanisms. Prof. Hague has championed the concept of biophysics as a "new branch of medicine," complementing surgery and pharmaceuticals.

He has authored numerous articles and papers on cell voltage, cancer biophysics, and regenerative medicine, and has built a global network of practitioners, clinics, and distributors spanning every continent. His vision is a world where effective medical treatment is accessible, affordable, and free from side effects.

Training Excellence

CellSonic Certificates

CellSonic practitioners are awarded certificates upon completion of their training, recognising their expert use of CellSonic VIPP technology.

Each certificate confirms that the practitioner has successfully completed CellSonic training, demonstrating competence in VIPP treatment protocols, machine operation, and patient care.

🎓

Training Certificate

Awarded on completion of the CellSonic training

Competency Verified

Practitioners demonstrate expert use of VIPP technology

📋

Ongoing Development

Continuing education and advanced training available

Our Technology

CellSonic VIPP Healing in Every Pulse

CellSonic is a hand-held thunderstorm. 25,000 volts create simultaneous forces that the body uses to heal itself — non-invasive, no drugs, no side effects.

Electrical Field

Corrects cell voltage — 25,000 volts raise diseased cells to healthy -75mV

💥

Pressure

Kills infection and promotes fibroblasts and osteoblasts for tissue and bone regeneration

🔬

Electrolysis

Forms oxygen to kill infection and hydrogen to promote angiogenesis at the treatment site

💡

Light

A range of frequencies from low to very high delivered by the hand-held thunderstorm

Certifications & Regulatory

🏅

CE Marked

European conformity for medical devices

📋

ISO 13485:2016

Quality management for medical devices

ISO 9001:2017

Quality management systems standard

🇺🇸

FDA Registered

Registration No. 3017514970

Want to Learn More?

We are not here writing a text book, only an introduction. This site is an invitation to ask questions — and we will reply quickly.

CellSonic